Denosumab Sequential Therapy

NCT03868033 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Zoledronic Acid
DRUG: Denosumab

Sponsor

National Taiwan University Hospital